Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Neuroscience

• Publication date

  2003-11-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0306-4522(03)00397-XPMID 14580949
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs

  2003cited by this paper
• Cocaine and Amphetamine Depress Striatal GABAergic Synaptic Transmission through D2 Dopamine Receptors

  2002cited by this paper
• GABAergic Interneurons: Implications for Understanding Schizophrenia and Bipolar Disorder

  2001cited by this paper
• Ultrastructural Localization of the Serotonin Transporter in Limbic and Motor Compartments of the Nucleus Accumbens

  1999cited by this paper
• Differential Induction of Fos-Like-Immunoreactivity in the Extended Amygdala after Haloperidol and Clozapine

  1999influential reference
• -Opposing actions of the ?-opioid receptor

  1998cited by this paper
• New atypical antipsychotic medications.

  1998influential reference
• mu-Opposing actions of the kappa-opioid receptor.

  1998cited by this paper
• Activation of midline thalamic nuclei by antipsychotic drugs

  1998cited by this paper
• Widespread expression of Fos protein induced by acute haloperidol administration in the rat brain

  1998influential reference
• The interface between dopamine neurons and the amygdala: implications for schizophrenia.

  1997cited by this paper
• Identification and characterization of the vesicular GABA transporter

  1997cited by this paper
• The thalamus as a site of action of antipsychotic drugs.

  1996cited by this paper
• Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment.

  1995influential reference
• D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs

  1995cited by this paper
• GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls.

  1995cited by this paper
• Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain.

  1995cited by this paper
• Monoamines and nitric oxide are employed by afferents engaged in midline thalamic regulation

  1995cited by this paper
• Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel locus of antipsychotic drug action.

  1995cited by this paper
• Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity.

  1994influential reference
• Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.

  1992influential reference
• Brain Maps: Structure of the Rat Brain

  1992cited by this paper
• Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics

  1992cited by this paper
• Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine.

  1992influential reference
• Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia.

  1992cited by this paper
• Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action.

  1992influential reference
• Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

  1991cited by this paper
• Serotonergic projections from the nucleus raphe dorsalis to the amygdala in the rat.

  1991cited by this paper
• Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia.

  1990cited by this paper
• Thalamic midline cell populations projecting to the nucleus accumbens, amygdala, and hippocampus in the rat

  1990cited by this paper
• The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.

  1990cited by this paper
• Reduced GABA uptake sites in the temporal lobe in schizophrenia.

  1989cited by this paper
• Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain

  1987cited by this paper
• In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action.

  1986cited by this paper
• Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro.

  1984cited by this paper
• Antipsychotic drug effects on the electrical activity of dopaminergic neurons

  1984cited by this paper
• Distribution of effects of haloperidol on energy metabolism in the rat brain.

  1982cited by this paper
• Dynorphin is a specific endogenous ligand of the kappa opioid receptor.

  1982cited by this paper
• Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.

  1980influential reference
• Turnover rates of γ-aminobutyric acid in substantia nigra, N. caudatus, globus pallidus and N. accumbens of rats injected with cataleptogenic and non-cataleptogenic antipsychotics

  1978cited by this paper
• gamma-Aminobutyric-acid deficiency in schizophrenia.

  1976cited by this paper

• Production of glycerolamines based conjugated γ-aminobutyric acids using microbial COX and LOX as successor enzymes to GAD.

  2023cites this paper
• Alterations of Astrocytes in the Context of Schizophrenic Dementia

  2020cites this paper
• Role of dorsal hippocampus &kgr; opioid receptors in contextual aversive memory consolidation in rats

  2018cites this paper
• Effect of long-term treatment with classical neuroleptics on NPQ/spexin, kisspeptin and POMC mRNA expression in the male rat amygdala

  2018cites this paper
• Stress increases GABAergic neurotransmission in CRF neurons of the central amygdala and bed nucleus stria terminalis.

  2016cites this paper
• Delta frequency optogenetic stimulation of a thalamic nucleus reuniens is sufficient to produce working memory deficits; relevance to schizophrenia

  2015cites this paper
• Delta frequency optogenetic stimulation of the thalamic nucleus reuniens is sufficient to produce working memory deficits: relevance to schizophrenia.

  2015cites this paper
• The dynorphin/kappa-opioid system of the brain as a promising target for therapy for dependence on psychoactive substances

  2015cites this paper
• Genetic and Functional Cartography of the Central Amygdala

  2015cites this paper
• Neurochemical properties of the synapses between the parabrachial nucleus-derived CGRP-positive axonal terminals and the GABAergic neurons in the lateral capsular division of central nucleus of amygdala

  2015cites this paper
• Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.

  2014cites this paper
• Occlusal Disharmony Transiently Impairs Learning and Memory in the Mouse by Increasing Dynorphin A Levels in the Amygdala.

  2013cites this paper
• The hidden side of drug action: brain temperature changes induced by neuroactive drugs

  2013cites this paper
• The dynorphin/j-opioid receptor system and its role in psychiatric

  2012cites this paper
• Investigation of Natural Product Scaffolds for the Development of Opioid Receptor Ligands

  2012cites this paper
• Dynorphins Regulate Fear Memory: from Mice to Men

  2012cites this paper
• Cannabinoid-1 (CB1) receptors in the mouse ventral pallidum are targeted to axonal profiles expressing functionally opposed opioid peptides and contacting NAPE-PLD terminals

  2012cites this paper
• Stress Produces Aversion and Potentiates Cocaine Reward by Releasing Endogenous Dynorphins in the Ventral Striatum to Locally Stimulate Serotonin Reuptake

  2012cites this paper
• Cannabinoid-1 receptors in the mouse ventral pallidum are targeted to axonal profiles expressing functionally opposed opioid peptides and contacting N-acylphosphatidylethanolamine-hydrolyzing phospholipase D terminals.

  2012cites this paper
• Mechanisms Underlying the Adverse Consequences of Stress: A Role for the Dynorphin/Kappa Opioid Receptor System, p38alpha MAPK, and the Serotonin Transporter

  2012cites this paper
• The dynorphin/κ-opioid receptor system and its role in psychiatric disorders

  2011cites this paper
• GABAA receptors as novel drug targets for treatment of mental disorders

  2010cites this paper
• Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use

  2010cites this paper
• Altered levels of synapsin I, dopamine transporter, dynorphin A, and neuropeptide Y in the nucleus accumbens and striatum at post‐puberty in rats treated neonatally with pregnenolone or DHEA

  2009influential citation
• Kappa-opioid ligands in the study and treatment of mood disorders.

  2009influential citation
• GABAA receptors in nucleus accumbens shell mediate the hyperphagia and weight gain following haloperidol treatment in rats.

  2009cites this paper
• 30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

  2009cites this paper
• Developmental changes in the mRNA expression of neuropeptides and dopamine and glutamate receptors in neonates and adult rats after ventral hippocampal lesion.

  2009cites this paper
• Tinnitus Treatment With Piribedil Guided by Electrocochleography and Acoustic Otoemissions

  2009cites this paper
• Potential Utility of Kappa Ligands in the Treatment of Mood Disorders

  2009cites this paper
• List of Tables vi List of Figures viii List of Abbreviations ix

  2008cites this paper
• The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward.

  2008cites this paper
• Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.

  2008cites this paper
• The effects of pentazocine, a kappa agonist, in patients with mania.

  2008cites this paper
• Adaptations neuronales dans les maladies psychiatriques associées à une hyperdopaminergie

  2008cites this paper
• Molecular mechanisms by which salvinorin A binds to and activates the κ-opioid receptor.

  2008cites this paper
• The supramammillo–septal–hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats

  2007cites this paper
• 8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor

  2007cites this paper
• Coexpression of prodynorphin and corticotrophin‐releasing hormone in the rat central amygdala: Evidence of two distinct endogenous opioid systems in the lateral division

  2007cites this paper
• Relationships between locomotor activation and alterations in brain temperature during selective blockade and stimulation of dopamine transmission.

  2007cites this paper
• Organization of endogenous opioids in the rostral agranular insular cortex of the rat

  2007cites this paper
• The Role of Astrocytes in the Pathophysiology of Schizophrenia.

  2007cites this paper
• The Role of Astrocytes in the Pathophysiology of Schizophrenia.

  2007cites this paper
• Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats

  2006cites this paper
• Zen-Brain Reflections

  2006cites this paper
• Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs.

  2006cites this paper
• Expression of noradrenergic alpha1, serotoninergic 5HT2a and dopaminergic D2 receptors on neurons activated by typical and atypical antipsychotic drugs.

  2006cites this paper
• Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum.

  2006cites this paper
• The role of extrastriatal dopamine D2 receptors in schizophrenia.

  2006cites this paper
• A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction.

  2005cites this paper
• Modelling spatial intensity for replicated inhomogeneous point patterns in brain imaging

  2004cites this paper
• Novel antipsychotics in schizophrenia

  2004cites this paper
• Opioid abuse and brain gene expression.

  2004cites this paper
• Endogenous opiates and behavior: 2003.

  2004cites this paper
• Brain inhibitory mechanisms involved in basic and higher integrated sleep processes.

  2004cites this paper